Immutep: Completes $12M placement
- Biotech company Immutep has successfully completed a $12M placement
- Approximately 96M ordinary shares issued to professional, sophisticated and institutional investors at a price of 12.5 cents each
- That price represents a 15.5 per cent discount to the volume weighted average price (VWAP) from the 15 days up to, and including, April 24
- Then the shares expected to settle on May 4 and issued on May 5
- The company also will use the money to drive the development of its clinical programs, research and development, and general working capital
- Then the company is down a slight 2.86 per cent and shares are currently trading for 17 cents each
